178 results
Page 3 of 9
8-K
EX-99.2
uslvk5ycm ybopcpx1
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
uqk6dj8 h8
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-1.1
eddo zanv3j
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
x1hjm insdgfn19c
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.2
xxwz r0jrfy9pp4i
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
7jmrj1s u9ep8fu4tn
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
wkbgghtc
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
dsoa2sn 3r
12 May 22
Departure of Directors or Certain Officers
4:10pm
8-K
EX-99.2
v9lah
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
p8uh oo7bc
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
0jj2z 798
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
tonux utk
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
7142qce78eqc215zdv4
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
2pimc9 4xqmtjc7h
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
ufciz8uyv9ylx twak
1 Jul 21
Other Events
6:11am